Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check5 days agoChange DetectedThis page update shows a system revision from v3.3.3 to v3.3.4 and does not modify study details, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLocations section updated to include a comprehensive list of trial site states; old state listings were removed and a new Revision: v3.3.3 tag appears.SummaryDifference2%

- Check55 days agoChange DetectedPublications section now notes that publications are automatically filled from PubMed, replacing the previous wording. Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check62 days agoChange DetectedThe funding-status notice on the page was removed. The study record content and navigation remain unchanged.SummaryDifference0.2%

- Check76 days agoChange DetectedMinor layout and styling adjustments observed; core study content and the list of locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check105 days agoChange DetectedAdded a government funding status notice and a new version tag (v3.2.0); removed a specific resource (Hb SS disease) and the previous version tag (v3.1.0).SummaryDifference4%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.